← SynDRA
SYN1947472
SynDRA canonical compound SYN1947472 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PYGL |
|---|
| Mechanism of action | glycogen phosphorylase inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CSNK1D
- CSNK1E
- MAPK14
- ABL1
- AURKA
- BRD4
- BRPF1
- CDK2
- FGFR3
- GSK3B
- HDAC6
- MAPK1
- TRIM24
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- RefChem:534911
- CP 316819
- CP 316 819
- WN4ZZX5ECD
- GPI819
- CP 316,819
- GPi 819
- CP316819
- UNII-WN4ZZX5ECD
- orb1704601
- SCHEMBL7237994
- AKOS024457674
- EBC-497112
- FC20581
- NCGC00370853-02
- MS-27230
- DB-219465
- E98693
- T22683
- CP-316819, >=98% (HPLC)
- 5-chloro-N-[(2S,3R)-3-hydroxy-4-[methoxy(methyl)amino]-4-oxo-1-phenylbutan-2-yl]-1H-indole-2-carboxamide
Look up SYN1947472 in the interactive SynDRA portal →